Itä-Suomen yliopisto, Kuopion kampus

Kuopio 70210

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease Dementia, Idiopathic Parkinson's Disease, Migraine, Mild Cognitive Impairment Due to Alzheimer's Disease

Studies at this site

• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD) — Stopped early
• A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments — Completed
• MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist — Completed